- Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens
- Great Place To Work® and Fortune Name Chiesi Group No. 23in 2024 World’s Best Workplaces™ List
- Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion
- Antibacterial peptides instrumental in efficiency against resistant bacteria
- Spinal cord stimulator with AI technology receives CE Mark certification
- J&J seek approval for first drug to treat high-risk smoldering myeloma
- Theramex receives recommendation for YSELTY in Scotland
- CMS commences formal review for Topical Oxygen Therapy coverage
- Johnson & Johnson receive MHRA approval for BALVERSA
- SolasCure partners with US Army for better wound care technology
- NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink
- FlyPharma Vienna 2024: An Event to Remember!
- Valneva Scotland supports local cancer charity Team Jak Foundation
- University of Edinburgh spinout Kynos Therapeutics acquired by Dr. Falk Pharma
- Darrin Schellin appointed new CEO at Pharma Tech Industries